Clinical Trial Update: IL-1RA, Acute Exercise, and Beta-cell Function [NA]

View source ↗

Summary

A clinical trial evaluating interleukin-1 receptor antagonist (anakinra) effects on beta-cell function during acute exercise in people with Type 2 Diabetes Mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Type 2 Diabetes Mellitus | NA | Status: WITHDRAWN